Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Transgenomic Acquires Gene Logic Biorepository | Contract Pharma

What are you searching for?

Sign in
Breaking News

Transgenomic Acquires Gene Logic Biorepository

Will use biologic samples to validate diagnostic assays

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Transgenomic, Inc. has entered into an agreement to acquire Gene Logic’s biorepository assets for $250,000 in cash. The biorepository contains thousands of human biological samples that can be used to validate diagnostic assays developed by Transgenomic.
 
Transgenomic will use the samples to develop and validate its REVEAL family of ICE COLD-PCR-based oncology assays, as well as its WAVE MCE System and SURVEYOR Scan Mutation Detection Kits.
 
“This transaction significantly strengthens Transgenomic’s position in translational medicine services, providing a deep source of clinical samples allowing us to validate new drug-associated genetic targets,” said Craig Tuttle, chief executive officer of Transgenomic. “The biorepository provides not only strategic and operational benefits, but also long-term cost savings. Acquiring specimens on a case-by-case basis is expensive and time-consuming; such expenditure would quickly surpass the cost of acquiring this asset.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters